This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08302/identifier/pdb/
n7http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB08302/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB08302/identifier/pubchem-substance/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08302/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08302
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB08302 n8:DB08302
dcterms:title
3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid
adms:identifier
n10:6006216 n11:99444773 n12:DB08302 n13:NRO
n3:IUPAC-Name
n4:271B4AEA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4AF0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4AEF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4AEC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4AED-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4AEE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4AE8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4AE6-363D-11E5-9242-09173F13E4C5 n4:271B4AE9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4AE7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4AF6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4AF7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4AF1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4AF2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4AF4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4AF3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4AF5-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4AFC-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4AFE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4AFF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4AFB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4AFA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4AFD-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4AEB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4AF8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4AF9-363D-11E5-9242-09173F13E4C5